1.866.448.4864
DiscoveRx: Additional Products - EFC BlockDetect™ Kit

PRODUCTS & SERVICES

Additional Products

– EFC BlockDetect™ Kit

EFC BlockDetect™ Kit


The EFC BlockDetect™ Kit is used to identify compounds that inhibit β-gal complementation or β-gal activity. β-gal complementation is DiscoveRx's core technology for both cell-based as well as biochemical assays. The assay has been validated for use in both 96-well and 384-well microplate formats. This kit is a companion product for DiscoveRx's PathHunter™ and HitHunter™ Product Lines.

Applications

All PathHunter™ Assays
All HitHunter™ cAMP Assays
All cAMP Hunter™ Assays

Representative Data:  Data for Positive control Titration

Positive Control* (nM)
Average RLU
Percent Activity
0 (No compound control)
23,127
100
0.0032
20,143
87
0.016
21,621
93
0.08
20,126
87
0.4
13,464
58
2
7,262
31
10
2,238
10
50
671
3
250
243
1

The positive control (supplied with the kit) is a proprietary compound known to
inhibit EFC activity in a dose-dependent manner. Percentage activity is calculated
by using the following formula: (Compound RLU/No Compound RLU) x 100%. These data demonstrate that the positive control inhibits EFC activity in a dose-dependent manner. Any compound that results in a 30% decrease in signal (RLU) when compared to the "no compound control" should be subjected to further investigation.

Current Ligand List

Products
Catalog #
Size
Product Inserts
Price
EFC BlockDect™ Kit
92-0004
800 data points

 

Copyright ©2009, DiscoveRx Corporation. TERMS AND CONDITIONS

Contact Us  |   Privacy Policy  |   Site Map  |   Careers